ArticleLeukemia2020
Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Abstract readPublished Erratum
In one paragraph
Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
34 authors.
Nicole PrutschClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Elisabeth GurnhoferClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Tobias SuskeClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Huan Chang LiangClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Michaela SchledererClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Simone RoosUnit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.
Lawren C WuDepartment of Oncology, Amgen Discovery Research, South San Francisco, CA, 94080, USA.
Ingrid Simonitsch-KluppClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Andrea Alvarez-HernandezClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Christoph KornauthClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Dario A LeoneClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Jasmin SvinkaInstitute of Cancer Research, Medical University of Vienna & Comprehensive Cancer Center (CCC), Vienna, Austria.
Robert EferlInstitute of Cancer Research, Medical University of Vienna & Comprehensive Cancer Center (CCC), Vienna, Austria.
Tanja LimbergerClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Astrid AufingerClinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria.
Nitesh ShirsathDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Peter WolfDepartment of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
Thomas HielscherDivision of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Christina SternbergUnit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.
Fritz AbergerDepartment of Molecular Biology, Cancer Cluster Salzburg, Faculty of Natural Sciences, Paris Lodron University, Salzburg, Austria.ORCID http://orcid.org/0000-0003-2009-6305
Johannes SchmoellerlLudwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.
Dagmar StoiberLudwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.
Birgit StroblInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria.
Ulrich JägerDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
Philipp B StaberDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology and Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
Florian GrebienLudwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.ORCID http://orcid.org/0000-0003-4289-2281
Richard MorigglLudwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.ORCID http://orcid.org/0000-0003-0918-9463
Mathias MüllerInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria.
Giorgio G InghiramiPathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
Takaomi SandaCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.ORCID http://orcid.org/0000-0003-1621-4954
A Thomas LookDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Suzanne D TurnerEuropean Research Initiative for ALK related malignancies (www.erialcl.net), Vienna, Austria.
Lukas Kenner *Clinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria. lukas.kenner@medunwien.ac.at.
Olaf Merkel *Clinical Institute of Pathology, Department for Experimental and Laboratory Animal Pathology, Medical University of Vienna, Vienna, Austria. olaf.merkel@meduniwien.ac.at.
Funding
Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in CancerR35CA210064 · NCI · DANA-FARBER CANCER INST · PI LOOK, A. THOMAS · 2016 to 2022
$7.3MAustrian Science Fund FWF I 4154Austrian Science Fund FWF I 4156NCI NIH HHS R35 CA210064
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.